Published in Br J Ophthalmol on March 01, 2003
The prevalence of pseudoexfoliation syndrome in Chinese people. Br J Ophthalmol (2004) 1.34
Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma. Am J Pathol (2010) 1.15
Prooxidant-antioxidant balance, peroxide and catalase activity in the aqueous humour and serum of patients with exfoliation syndrome or exfoliative glaucoma. Graefes Arch Clin Exp Ophthalmol (2008) 1.02
Elevated aqueous humour tissue inhibitor of matrix metalloproteinase-1 and connective tissue growth factor in pseudoexfoliation syndrome. Br J Ophthalmol (2005) 0.95
Lipid peroxidation: pathophysiological and pharmacological implications in the eye. Front Physiol (2013) 0.93
Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. Mol Vis (2008) 0.92
Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol (2004) 0.91
Increased levels of Helicobacter pylori IgG antibodies in aqueous humor of patients with primary open-angle and exfoliation glaucoma. Graefes Arch Clin Exp Ophthalmol (2003) 0.88
Kinetics and Mechanisms of Oxidative Cleavage of HIV RRE RNA by Rev-Coupled Transition Metal Chelates. Chem Sci (2013) 0.84
Quantitative analysis of SOD2, ALDH1A1 and MGST1 messenger ribonucleic acid in anterior lens epithelium of patients with pseudoexfoliation syndrome. Mol Vis (2013) 0.84
Aqueous humor and serum erythropoietin levels in patients with pseudoexfoliation syndrome and pseudoexfoliative glaucoma. Int Ophthalmol (2010) 0.82
Disturbed oxidant/antioxidant balance in aqueous humour of patients with exfoliation syndrome. Jpn J Ophthalmol (2014) 0.79
Asymmetric dimethylarginine is not elevated in exfoliation syndrome but symmetric dimethylarginine is related to exfoliative glaucoma. Graefes Arch Clin Exp Ophthalmol (2007) 0.77
Exfoliation syndrome in sub-Saharan Africa. Int Ophthalmol (2014) 0.76
Directed Therapy: An Approach to the Improved Treatment of Exfoliation syndrome. Middle East Afr J Ophthalmol (2009) 0.76
[Functional significance of adenosine receptors in the eye and their dysregulation in pseudoexfoliation syndrome]. Ophthalmologe (2005) 0.75
Directed therapy for exfoliation syndrome. Open Ophthalmol J (2009) 0.75
Comparison study of OCT, HRT and VF findings among normal controls and patients with pseudoexfoliation, with or without increased IOP. Clin Ophthalmol (2014) 0.75
Serum Uric Acid, Alanine Aminotransferase, Hemoglobin and Red Blood Cell Count Levels in Pseudoexfoliation Syndrome. J Ophthalmol (2015) 0.75
Transforming growth factor beta in tissue fibrosis. N Engl J Med (1994) 9.73
Exfoliation syndrome. Surv Ophthalmol (2001) 3.55
Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med (2000) 3.53
Oxidative stress-related molecules and liver fibrosis. J Hepatol (2001) 2.75
Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids. Proc Natl Acad Sci U S A (1992) 2.51
Redox-mediated activation of latent transforming growth factor-beta 1. Mol Endocrinol (1996) 2.44
Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol (1999) 2.40
Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis (2001) 1.54
Exfoliation syndrome in various ethnic populations. Acta Ophthalmol Suppl (1988) 1.52
IPF2alpha-I: an index of lipid peroxidation in humans. Proc Natl Acad Sci U S A (1998) 1.43
Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. Exp Eye Res (2001) 1.39
Antioxidant activity of vitamin C in iron-overloaded human plasma. J Biol Chem (1997) 1.38
Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int (2001) 1.33
The isoprostanes: their quantification as an index of oxidant stress status in vivo. Drug Metab Rev (2001) 1.31
Preclinical diagnosis of pseudoexfoliation syndrome. Arch Ophthalmol (1987) 1.25
Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol (1993) 1.19
Pseudoexfoliation, an environmental disease? Trans Ophthalmol Soc U K (1979) 1.15
Ocular oxidants and antioxidant protection. Proc Soc Exp Biol Med (1998) 1.09
Fluorescein angiography of the vessels of the iris in pseudoexfoliation of the lens capsule, capsular glaucoma and some other forms of glaucoma. Acta Ophthalmol Suppl (1969) 1.06
Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J Biol Chem (1996) 1.05
Exfoliation syndrome. Curr Opin Ophthalmol (2001) 1.02
Ascorbic acid concentration is reduced in the aqueous humor of patients with exfoliation syndrome. Am J Ophthalmol (2002) 1.00
F(2)-isoprostanes mediate high glucose-induced TGF-beta synthesis and glomerular proteinuria in experimental type I diabetes. Kidney Int (2000) 0.99
Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells. J Cardiovasc Pharmacol (2001) 0.99
Free-radical-generated F2-isoprostane stimulates cell proliferation and endothelin-1 expression on endothelial cells. Kidney Int (1999) 0.96
A novel mechanism for vasoconstrictor action of 8-isoprostaglandin F2 alpha on retinal vessels. Am J Physiol (1998) 0.96
8-Iso-prostaglandin f(2alpha) reduces trophoblast invasion and matrix metalloproteinase activity. Hypertension (2000) 0.95
Water soluble antioxidants in mammalian aqueous humor: interaction with UV B and hydrogen peroxide. Vision Res (1998) 0.93
Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke (1997) 0.91
Iris vasculopathy in exfoliation syndrome. An immunocytochemical study. Acta Ophthalmol (Copenh) (1991) 0.90
Low-dose angiotensin II increases free isoprostane levels in plasma. Hypertension (1999) 0.89
Morphology of iris vasculopathy in exfoliation glaucoma. Acta Ophthalmol (Copenh) (1993) 0.88
Transforming and insulin-like growth factors in the aqueous humour of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol (2001) 0.88
Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation. Atherosclerosis (2002) 0.88
The damaging effect of UV rays below 320 nm on the rabbit anterior eye segment. II. Enzyme histochemical changes and plasmin activity after prolonged irradiation. Acta Histochem (1995) 0.84
Immunogold localisation of laminin in normal and exfoliative iris. Br J Ophthalmol (1990) 0.83
Protein quantification and electrophoresis in aqueous humor of pseudoexfoliation eyes. Invest Ophthalmol Vis Sci (1994) 0.82
Increased growth factor activity in the aqueous humour of patients with exfoliation syndrome. Graefes Arch Clin Exp Ophthalmol (2000) 0.80
The significance of ascorbate in the aqueous humour protection against UV-A and UV-B. Exp Eye Res (1996) 0.79
Changes of iris vessels in capsular glaucoma: three-dimensional and electron microscopic studies. Jpn J Ophthalmol (1985) 0.78
The isoprostanes: novel markers of lipid peroxidation and potential mediators of oxidant injury. Adv Prostaglandin Thromboxane Leukot Res (1995) 0.77
The appearance of active plasminogen activator of urokinase type (u-PA) in the rabbit anterior eye segment irradiated by UVB rays. A histochemical and biochemical study. Acta Histochem (1995) 0.77
Microplate assay of ascorbic acid in aqueous humor with bicinchoninic acid. J Ocul Pharmacol Ther (1997) 0.77
Quenching of UV-induced fluorescence by ascorbic acid in the aqueous humour. Acta Ophthalmol Scand (1995) 0.76
Identification of a gene that causes primary open angle glaucoma. Science (1997) 8.14
Genetic evidence for two species of elephant in Africa. Science (2001) 4.13
Exfoliation syndrome. Surv Ophthalmol (2001) 3.55
Analysis of myocilin mutations in 1703 glaucoma patients from five different populations. Hum Mol Genet (1999) 3.24
Ultrasound biomicroscopy in pigment dispersion syndrome. Ophthalmology (1994) 2.98
Prevent Blindness America visual field screening study. The Prevent Blindness America Glaucoma Advisory Committee. Am J Ophthalmol (1995) 2.88
Trabeculectomy with mitomycin-C in the treatment of pediatric glaucomas. Ophthalmology (2000) 2.70
Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly. Am J Hum Genet (1998) 2.34
Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations. Ophthalmology (1998) 2.31
Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol (1997) 2.31
Factors affecting image acquisition during scanning laser polarimetry. Ophthalmic Surg Lasers (1998) 2.23
Prevention of blinking alters iris configuration in pigment dispersion syndrome and in normal eyes. Ophthalmology (1995) 2.21
Risk factors for glaucoma filtering bleb infections. Arch Ophthalmol (2000) 2.13
Imaging congenital optic disc pits and associated maculopathy using optical coherence tomography. Arch Ophthalmol (1996) 1.94
Structural and functional assessment of the macular region in patients with glaucoma. Br J Ophthalmol (2006) 1.92
Racial differences in optic nerve head parameters. Arch Ophthalmol (1989) 1.92
An interocular comparison of the multifocal VEP: a possible technique for detecting local damage to the optic nerve. Invest Ophthalmol Vis Sci (2000) 1.88
Morphometry of the human lamina cribrosa surface. Invest Ophthalmol Vis Sci (1991) 1.81
Ultrasound biomicroscopy in plateau iris syndrome. Am J Ophthalmol (1992) 1.70
Late infectious endophthalmitis from exposed glaucoma setons. Arch Ophthalmol (1992) 1.58
Untreated 24-h intraocular pressures measured with Goldmann applanation tonometry vs nighttime supine pressures with Perkins applanation tonometry. Eye (Lond) (2009) 1.57
Age-related decline of disc rim area in visually normal subjects. Ophthalmology (1992) 1.55
Heidelberg retina tomography and optical coherence tomography in normal, ocular-hypertensive, and glaucomatous eyes. Ophthalmology (1999) 1.53
New patterns of infecting organisms in late bleb-related endophthalmitis: a ten year review. Eye (Lond) (1998) 1.53
Late bleb-related endophthalmitis after trabeculectomy with adjunctive 5-fluorouracil. Ophthalmology (1991) 1.52
Diurnal intraocular pressure reduction with latanoprost 0.005% compared to timolol maleate 0.5% as monotherapy in subjects with exfoliation glaucoma. Eye (Lond) (2004) 1.51
S (blue) cone pathway vulnerability in retinitis pigmentosa, diabetes and glaucoma. Invest Ophthalmol Vis Sci (1989) 1.50
Measurement of ultrasound biomicroscopy images: intraobserver and interobserver reliability. Invest Ophthalmol Vis Sci (1994) 1.50
Pseudoexfoliation syndrome and aneurysms of the abdominal aorta. Lancet (2001) 1.50
Quantitative assessment of the anterior segment using ultrasound biomicroscopy. Curr Opin Ophthalmol (2000) 1.50
Initial 5-fluorouracil trabeculectomy in uncomplicated glaucoma. Ophthalmology (1991) 1.50
Late-onset bleb leaks after glaucoma filtering surgery. Arch Ophthalmol (1998) 1.48
Reproducibility of retinal thickness measurements in normal eyes using optical coherence tomography. Ophthalmic Surg Lasers (1998) 1.47
The Glaucoma Symptom Scale. A brief index of glaucoma-specific symptoms. Arch Ophthalmol (1998) 1.46
Ultrasound biomicroscopy in pseudophakic malignant glaucoma. Ophthalmology (1993) 1.46
Bleb-related ocular infection in children after trabeculectomy with mitomycin C. Ophthalmology (1997) 1.46
Combined phacoemulsification and goniosynechialysis for uncontrolled chronic angle-closure glaucoma after acute angle-closure glaucoma. Ophthalmology (1999) 1.42
Soft contact lens modification of the ocular cup for high-resolution ultrasound biomicroscopy. Ophthalmic Surg (1993) 1.40
Congenital ectropion uveae with glaucoma. Ophthalmology (1984) 1.37
Intraocular suture ligature to reduce hypotony following Molteno seton implantation. Ophthalmic Surg (1992) 1.37
Pericardial patch grafts in glaucoma implant surgery. J Glaucoma (1998) 1.30
Exfoliation syndrome and occludable angles. Trans Am Ophthalmol Soc (1994) 1.30
Clinical signs of the pseudoexfoliation syndrome. Ophthalmology (1986) 1.29
Treatment of the Weill-Marchesani syndrome. Ann Ophthalmol (1981) 1.29
Keratopathy in pseudoexfoliation syndrome as a cause of corneal endothelial decompensation: a clinicopathologic study. Ophthalmology (2000) 1.28
Optical coherence tomography and scanning laser polarimetry in normal, ocular hypertensive, and glaucomatous eyes. Am J Ophthalmol (2000) 1.27
Ocular findings in oculodermal melanocytosis. Arch Ophthalmol (1990) 1.26
Increase in iris-lens contact after laser iridotomy for pupillary block angle closure. Am J Ophthalmol (1996) 1.25
Preclinical diagnosis of pseudoexfoliation syndrome. Arch Ophthalmol (1987) 1.25
Optic coherence tomography of optic disk pit maculopathy. Am J Ophthalmol (1996) 1.23
Patterns of retinal ganglion cell survival after brain-derived neurotrophic factor administration in hypertensive eyes of rats. Neurosci Lett (2001) 1.21
Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma. Br J Ophthalmol (2008) 1.20
Effect of a tight necktie on intraocular pressure. Br J Ophthalmol (2003) 1.19
Differential diagnosis of anterior segment cysts by ultrasound biomicroscopy. Ophthalmology (1999) 1.18
A comparison between microperimetry and standard achromatic perimetry of the central visual field in eyes with glaucomatous paracentral visual-field defects. Br J Ophthalmol (2009) 1.17
Ultrasound biomicroscopy dark room provocative testing: a quantitative method for estimating anterior chamber angle width. Jpn J Ophthalmol (2000) 1.17
Exfoliation (pseudoexfoliation) syndrome: toward a new understanding. Proceedings of the First International Think Tank. Acta Ophthalmol Scand (2001) 1.15
Comparisons of anterior segment biometry between Chinese and Caucasians using anterior segment optical coherence tomography. Br J Ophthalmol (2010) 1.13
Diode laser transscleral cyclophotocoagulation for refractory glaucoma. J Glaucoma (2001) 1.13
Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation. Br J Ophthalmol (2003) 1.12
Retinal nerve fibre thickness measured with optical coherence tomography accurately detects confirmed glaucomatous damage. Br J Ophthalmol (2007) 1.12
Peripapillary nerve fiber layer thickness measurement reproducibility using scanning laser polarimetry. J Glaucoma (1998) 1.12
Continuous wave argon laser iridectomy in angle-closure glaucoma. Am J Ophthalmol (1979) 1.12
Pseudotumor cerebri appearing with unilateral papilledema after trabeculectomy. Arch Ophthalmol (1997) 1.11
Filtering valve implant surgery for eyes wtih neovascular glaucoma. Am J Ophthalmol (1980) 1.11
Axial length and optic disc size in normal eyes. Br J Ophthalmol (2006) 1.11
Glaucoma in phakomatosis pigmentovascularis. Ophthalmology (1997) 1.11
Ciliary body enlargement and cyst formation in uveitis. Br J Ophthalmol (1996) 1.10
Argon laser iridectomy in densely pigmented irides. Am J Ophthalmol (1982) 1.10
Detection of glaucoma using operator-dependent versus operator-independent classification in the Heidelberg retinal tomograph-III. Br J Ophthalmol (2006) 1.10
Follow-up of angle-closure glaucoma suspects. Am J Ophthalmol (1993) 1.09
The combined effect of brain-derived neurotrophic factor and a free radical scavenger in experimental glaucoma. Invest Ophthalmol Vis Sci (2000) 1.09
Inadvertent corneal indentation can cause artifactitious widening of the iridocorneal angle on ultrasound biomicroscopy. Ophthalmic Surg Lasers (2000) 1.08
Lack of association of histocompatibility antigens with primary open-angle glaucoma. Arch Ophthalmol (1978) 1.07
Ginkgo biloba extract increases ocular blood flow velocity. J Ocul Pharmacol Ther (1999) 1.07
Coexistence of Prader-Willi syndrome, congenital ectropion uveae with glaucoma, and factor XI deficiency. JAMA (1986) 1.06
Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. Invest Ophthalmol Vis Sci (1993) 1.06
A histopathologic study of iris changes in pseudoexfoliation syndrome. Ophthalmology (1995) 1.06
Gastric adenocarcinoma presenting as an eyelid and conjunctival mass. Eur J Ophthalmol (1992) 1.05
Acute angle-closure glaucoma in a patient with acquired immunodeficiency syndrome successfully treated with argon laser peripheral iridoplasty. Ophthalmic Surg (1990) 1.05
An attempt to detect glaucomatous damage to the inner retina with the multifocal ERG. Invest Ophthalmol Vis Sci (2000) 1.05
In vivo increase of the human lens equatorial diameter during accommodation. Am J Physiol (1996) 1.05
The effects of glaucoma on the latency of the multifocal visual evoked potential. Br J Ophthalmol (2006) 1.05
Optic nerve head and nerve fiber layer in Alzheimer's disease. Arch Ophthalmol (1991) 1.04
Trabeculectomy at the inferior limbus. Arch Ophthalmol (1996) 1.03
Glaucoma in oculodermal melanocytosis. Ophthalmology (1990) 1.03
Intraocular pressure following phacoemulsification in patients with and without exfoliation syndrome: a 2 year prospective study. Br J Ophthalmol (2006) 1.03
Retinal nerve fiber layer thickness remains unchanged following laser-assisted in situ keratomileusis. Am J Ophthalmol (2001) 1.02
Vitamin deficiency and hyperhomocysteinemia in pseudoexfoliation glaucoma. J Neural Transm (Vienna) (2007) 1.02
Anterior segment implantation cysts. Ultrasound biomicroscopy with histopathologic correlation. Arch Ophthalmol (1998) 1.02
Pseudoexfoliation syndrome in eyes with ischemic central retinal vein occlusion. A histopathologic and electron microscopic study. Acta Ophthalmol Scand (2001) 1.02
Argon laser treatment for medically unresponsive attacks of angle-closure glaucoma. Am J Ophthalmol (1982) 1.02
Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. Ger J Ophthalmol (1994) 1.01
Iris and ciliary body melanomas: ultrasound biomicroscopy with histopathologic correlation. Arch Ophthalmol (2000) 1.01
Long-term results of valve implants in filtering surgery for eyes with neovascular glaucoma. Am J Ophthalmol (1983) 1.00
Visual evoked potential assessment of the effects of glaucoma on visual subsystems. Vision Res (1998) 1.00
Clinical comparison of dipivalyl epinephrine and epinephrine in the treatment of glaucoma. Am J Ophthalmol (1979) 1.00
Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study. Arch Ophthalmol (2001) 1.00
Scanning laser polarimetry measurements after laser-assisted in situ keratomileusis. Am J Ophthalmol (2000) 0.99